B.Sc. in Biological Sciences from the University of Campinas (UNICAMP - 2021). As an undergraduate research fellow, developed projects focused on the construction, production, and validation of monoclonal antibodies for the treatment of acute lymphoblastic leukemia at the Boldrini Research Center. Received fellowships from CNPq (20192020) and FAPESP (20202021). Between 2022 and 2024, worked as a Research Assistant in the Laboratory of Mucosal Immunology at Rockefeller University (USA), where research focused on the effects of IgA in suppressing epithelial cell proliferation and tumorigenesis, as well as the characterization of clonal dynamics of infiltrating CD4+ T lymphocytes in the intestinal environment under homeostatic conditions. Currently a Ph.D. student at Rockefeller University, with research interests in Immunology and Molecular Biology. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
One of the major failures in the treatment of acute lymphoblastic leukemia (ALL) is the relapse process, in which leukemic cells resistant to chemotherapy do not respond to treatment. Currently, new therapeutic approaches have been incorporated into leukemia treatments, contributing to significant progress in the outcome of these malignancies. Targeted therapies, such as the use of monocl…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID